Tesamorelin
Also known as: Egrifta
How It Works
Synthetic GHRH analog. FDA-approved for HIV-associated lipodystrophy. Potent stimulator of endogenous GH production.
What It's Used For
Administration
Safety & Side Effects
Possible Side Effects
- ⚠Injection site reactions
- ⚠Arthralgia
- ⚠Peripheral edema
- ⚠Paresthesia
Contraindications
- ✘Active cancer
- ✘Pregnancy
- ✘Pituitary pathology
- ✘Hypersensitivity
Research Summary
FDA-approved. Demonstrated significant reduction in visceral adipose tissue and improvement in lipid profiles. Emerging data on cognitive benefits (NCBI, 2023).
References
- Falutz J et al. N Engl J Med. 2007
- Stanley TL et al. Ann Intern Med. 2024
Legal & Availability
FDA-approved (prescription)
This peptide requires a prescription from a licensed provider.
Dosing Protocol
Stacks Well With
Full stacking protocols and cycling schedules available with Pro subscription.
Is Tesamorelin Right for You?
Our AI analyzes your symptoms, labs, and medical history to determine if this peptide fits your protocol — and at what dose.
Is Tesamorelin right for you?
Get a free personalized analysis based on your symptoms and goals — delivered to your inbox.
This information is for educational purposes only and is not medical advice. Do not use any peptide without consulting a qualified healthcare provider. BioRoot AI is a clinical decision support tool — not a medical provider.